Sahingoz, MineSonmez, Erdem Onder2024-02-232024-02-2320151304-38891304-3897https://doi.org/10.15197/ejgm.01268https://hdl.handle.net/20.500.12452/15411Selective serotonin reuptake inhibitors (SSRIs) are widely used for treating depressive and anxiety disorders. Although SSRIs have a safety profile, some authors have reported that they associated with an increased risk of bleeding events. We report a case of paroxetine- and sertraline-associated ecchymoses in a patient with depression.eninfo:eu-repo/semantics/openAccessEcchymosisParoxetineSertralineSpontaneus BleedingArticle1243563572-s2.0-84949769153WOS:00038275190001410.15197/ejgm.01268